Table 3 Gitelman syndrome (including definite or probable cases) and GHD: cases from the literature
From: Classic Bartter syndrome complicated with profound growth hormone deficiency: a case report
Reference | Age, years | Sex | Mutation | GH peak (μg/L) to stimulants | IGF-1 |
|---|---|---|---|---|---|
[12] | 3 | M | 2614fr/unknown (SLC12A3) | <8 (INS), <8 (ARG), <8 (CLN) | Not determined |
9 | F | G186D/unknown (SLC12A3) | 6 (CLN) | 89ng/mL | |
[5] | 3 | M | Not determined | 3.3 (l-DOPA), 7.3 (CLN) | 0.26U/mL |
9 | F | Not determined | 9.2 (l-DOPA), 4.8 (CLN) | 0.67U/mL | |
19 | F | Not determined | 6.0 (CLN) | Not determined | |
[6] | 7 | M | Not determined | 9.8 (INS + ARG) | Not determined |
[11] | 9 | M | Not determined | 2.1 (INS), 3.2 (CLN), 1.8 (l-DOPA) | 55ng/mL |
[13] | 10 | F | Not determined | 7.5 (l-DOPA), 6.9 (CLN) | Normal |
[14] | 11 | M | Not determined | 10.8 (GRF), 7.0 (CLN) | 0.43U/mL |
[15] | 11 | M | Not determined | 5 (INS), 1 (CLN), 13 (GRF) | 292ng/mL |
[4] | 11 | M | Not determined | 11 (CLN), 3.1 (GLC) | 0.74U/mL |
[16] | 13 | M | Not determined | 5.4 (INS), 5.4 (ARG), 12 (GLC-PPL) | 0.19U/mL |